Cancer Research

Oncolytics Biotech Inc. Collaborators To Present Positive Interim Results Of U.K. Phase Ia/Ib Combination REOLYSIN(R) And Radiat

CALGARY, Canada, October 24 /PRNewswire/-- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced that a poster presentation covering interim results from a U.K. Phase Ia/Ib combination REOLYSIN(R)/radiation clinical trial ...

Article - Anna Ohlden - Oct 24 2007 - 1:10am

Mersana Therapeutics Reports Phase I Results For XMT-1001 In Patients With Solid Tumors At AACR-NCI-EORTC International Conferen

CAMBRIDGE, Massachusetts, October 24 /PRNewswire/--- favorable pharmacokinetic and safety data observed in first clinical trial of novel Fleximer(TM) anticancer agent- ...

Article - Anna Ohlden - Oct 24 2007 - 8:03am

BioWa Announces Extended Licensing To MedImmune Of BioWa's POTELLIGENT(R) Technology For Use In Antibody Research And Developmen

PRINCETON, New Jersey, October 24 /PRNewswire/-- BioWa, Inc. (BioWa) announced today that it has entered into a second agreement with MedImmune to provide additional access to BioWa's patented POTELLIGENT(R) Technology platform for the development of ...

Article - Anna Ohlden - Oct 24 2007 - 3:14pm

Vampires Beware: Scripps Scientists Describe Molecular Basis Of Raw Garlic's Pungency

Cooked or raw, garlic has been a favorite ingredient of cooks for thousands of years, but almost any cook will tell you there's a major difference: raw garlic is much more pungent than cooked. Now, a group of scientists from The Scripps Research Insti ...

Article - News Staff - Jul 4 2009 - 12:29pm

Study: Women With Alcoholic Family Histories Have A Greater Sweet Tooth

More than 250 million women worldwide smoke tobacco. Compared to men, women have a greater risk of smoking-related diseases, and also have more difficulty quitting. A new study, the first of its kind, has found that cigarette smoking and having a family hi ...

Article - News Staff - Oct 25 2007 - 3:09am

DARA BioSciences, Inc. Announces New Board Chairman

RALEIGH, North Carolina, October 25 /PRNewswire/-- DARA BioSciences announced that current Director, President and CEO Richard A. Franco, Sr. has been appointed Chairman of the Board of Directors. The announcement was made following the October 23 Board o ...

Article - Anna Ohlden - Oct 25 2007 - 6:47am

Connection Between Smoking, More Aggressive Breast Cancer Ruled Out

Smoking cigarettes is associated with an increased risk of cancers of the lung, head and neck, esophagus, bladder and many others and also affects response to anti-cancer treatments. But smoking does not result in more advanced stage diagnoses or aggressiv ...

Article - News Staff - Oct 29 2007 - 12:25am

Xenomics Announces License With Asuragen For NPM1 Leukemia Diagnostics

NEW YORK, October 29 /PRNewswire/-- Xenomics, Inc., (Pink Sheets: XNOM; FWB:X37) announces that it has granted Asuragen, Inc. co-exclusive worldwide rights to incorporate NPM1 technology into Asuragen's molecular diagnostic products. Under the terms ...

Article - Anna Ohlden - Oct 29 2007 - 7:31am

Agendia BV Appoints Clinical And Scientific Advisory Board

AMSTERDAM, October 29 /PRNewswire/--- Six Eminent Cancer Researchers Advise Agendia Agendia BV, a world leader in the rapidly evolving field of cancer molecular diagnostics has appointed six members to its Clinical and Scientific Advisory Board. The newly ...

Article - Anna Ohlden - Oct 29 2007 - 12:11pm

'Cancer Vaccine' Could Go Into Human Clinical Trial Next Year

When cells become cancerous, the sugars on their surfaces undergo distinct changes that set them apart from healthy cells. For decades, scientists have tried to exploit these differences by training the immune system to attack cancerous cells before they c ...

Article - News Staff - Oct 29 2007 - 12:27pm